MCK Form 4: SVP Rutledge Napoleon B. Jr. Sells 329 Shares via 10b5-1 Plan
Rhea-AI Filing Summary
Rutledge Napoleon B. Jr., SVP, Controller & CAO of McKesson Corporation (MCK), reported a sale of common stock under a pre-existing Rule 10b5-1 trading plan. The filing shows a transaction on 08/08/2025 in which 329 shares were sold at $663.67 per share, leaving the reporting person with 657 shares held directly. The form indicates the sale was executed pursuant to a plan adopted February 7, 2025, and the form was signed by an attorney-in-fact on 08/11/2025. The filing contains only this single non-derivative sale disclosure and does not provide additional company financial information.
Positive
- Sale executed under a documented Rule 10b5-1 plan, which supports non-discretionary trading intent
- Full Form 4 disclosure includes transaction details: date, price ($663.67), quantity (329 shares), and post-transaction holdings (657 shares)
Negative
- Insider reduced direct holdings by 329 shares, leaving 657 shares owned directly
- Filing contains no additional context about other holdings, other transactions, or company financials
Insights
TL;DR: A routine insider sale of 329 shares under a 10b5-1 plan; impact on capitalization is immaterial.
The disclosed sale of 329 shares at $663.67 reduces the reporting person’s direct holdings to 657 shares. Executions under Rule 10b5-1 plans are pre-arranged and generally indicate a non-discretionary sale rather than ad hoc trading. Given the small absolute share count relative to McKesson’s market capitalization, the transaction is unlikely to be material to investors or to affect the company’s capital structure.
TL;DR: Properly disclosed as a Rule 10b5-1 sale and executed via attorney-in-fact signature; disclosure meets basic Form 4 requirements.
The form identifies the reporter, relationship to the issuer, transaction date, transaction code (S for sale), number of shares sold, sale price, and post-transaction holdings, and includes an explanatory note that the sale was pursuant to a February 7, 2025 plan. The signature by an attorney-in-fact is present with a date. The filing therefore contains the core elements required for Section 16 reporting for a single non-derivative sale.